Ehi focuses on venture opportunities in the healthcare sector, including therapeutics, medical devices, diagnostics, digital health and health tech IT and services.

Ehi was previously at McKinsey & Company’s Life Sciences practice, where he advised clients in the pharmaceutical and medical products industries on corporate strategy, M&A and R&D.

Ehi has an MD and a Ph.D. from the MSTP at Washington University School of Medicine. During his Ph.D., he published papers on the genetic mechanisms of risk in congenital heart disease. He also has bachelor’s degrees in Biology and Chemistry from Emory University, where he graduated with highest honors.